Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The superficial and deep veins of the lower extremity are anatomical groups of veins responsible for draining deoxygenated blood from the legs back to the heart. Superficial veins like the great and small saphenous veins run close to the skin and are visible; deep veins such as the femoral, popliteal, tibial, and fibular veins travel deeper and accompany major arteries. Venous valves are present to prevent reflux, and perforating veins connect superficial and deep systems. Clinical disorders include DVT (blood clots in the deep system), varicose veins (dilation of superficial veins from valve failure), and use in vascular surgery (e.g., saphenous vein grafts). This entity is not a molecular or receptor target but an anatomical structure with clinical, physiological, and surgical significance.
Anticoagulants: prevent clot formation or propagation by inhibiting components of the coagulation cascade. Thrombolytics: dissolve existing clots by promoting fibrinolysis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superficial and deep veins of the lower extremity.